Search for: "Mylan, Inc."
Results 61 - 80
of 587
Sorted by Relevance
|
Sort by Date
14 Jun 2011, 9:24 pm
• Defendants: Mylan Inc.; Mylan Pharmaceuticals, Inc. [read post]
12 Aug 2010, 9:18 pm
By James DeGiulio -- Cephalon and Mylan Pharmaceuticals Agree to Drop Two Patents from Nuvigil Patent Suit Cephalon Inc. and Mylan Pharmaceuticals Inc. have agreed to drop two of the three patents originally involved in their infringement suit over the narcolepsy drug Nuvigil. [read post]
27 Oct 2006, 9:43 am
" Life Techs., Inc. v. [read post]
13 Nov 2011, 9:40 pm
• Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc. [read post]
29 Jan 2012, 8:59 pm
• Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc. [read post]
4 Mar 2012, 8:24 pm
• Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc. [read post]
13 Feb 2011, 9:08 pm
Mylan Pharmaceuticals Inc. et al. 1:11-cv-00127; filed February 10, 2011 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc. [read post]
27 Feb 2011, 8:59 pm
Mylan Inc. et al. 1:11-cv-01285; filed February 23, 2010 in the Northern District of Illinois • Plaintiff: The Medicines Company • Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc.; Bioniche Pharma USA, LLC Infringement of U.S. [read post]
29 Feb 2012, 9:29 pm
Mylan Inc. has agreed to pay $57 million to resolve allegations that it fraudulently increased the reimbursement amount for its drugs by reporting inflated prices. [read post]
10 Jan 2012, 12:43 pm
Mamula, Reporter for the Pittsburgh Business Times: Takeda Pharmaceutical, Watson Pharmaceuticals and Andrx Labs have sued generic drugmaker Mylan Inc. for patent infringement in connection with its plans to market pioglitazone hydrochloride and extended release metformin hydrochloride tablets, Canonsburg-based Mylan announced Monday. [read post]
8 Jan 2012, 9:05 pm
Mylan, Inc. et al. 1:12-cv-00024; filed January 3, 2011 in the Southern District of New York • Plaintiffs: Takeda Pharmaceutical Co.; Takeda Pharmaceuticals North America, Inc.; Takeda Global Research and Development Center, Inc.; Watson Pharmaceuticals, Inc.; Andrx Labs, LLC • Defendants: Mylan, Inc.; Mylan Pharmaceuticals, Inc. [read post]
20 Jun 2010, 8:51 pm
LLC; Sugen Inc.; C P Pharmaceuticals International CV • Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc. [read post]
1 Dec 2017, 2:53 pm
Mylan Laboratories Limited et al., Civil Action No. 16-224-LPS (D.Del., December 1, 2017), the Court denied without prejudice the motion to dismiss for improper venue or, in the alternative, to transfer venue to the Northern District of West Virginia of Defendant Mylan Laboratories Limited, Mylan, Inc. and Mylan Pharmaceutical Inc. [read post]
1 Aug 2010, 9:59 pm
• Defendant: Mylan Pharmaceuticals Inc. [read post]
18 Dec 2011, 3:45 pm
• Defendants: Mylan Pharmaceuticals Inc.; Mylan, Inc. [read post]
21 Jul 2022, 9:15 am
Mylan Pharmaceuticals Inc. [read post]
21 Jul 2022, 9:15 am
Mylan Pharmaceuticals Inc. [read post]
25 Aug 2017, 2:25 pm
On Thursday, August 17, 2017, the Department of Justice, announced that Mylan Inc. and Mylan Specialty L.P. [read post]
30 Dec 2021, 8:07 am
Mylan Pharmaceuticals Inc., November 30, 2021, Reyna, J.). [read post]
9 Jul 2010, 3:24 pm
As one of the leading manufacturers of generic drugs in the world, Mylan received final approval by the Food and Drug Administration (FDA) in 2009 to manufacture a generic substitute for the anti-seizure medication, Keppra, developed by UCB Pharmaceuticals Inc. and marketed to epilepsy patients. [read post]
